Lipid metabolizing enzyme ACSM2B is a potential negative regulator of liver cancer progression

• Zhengfeng Xu,
• Hongwei Yu,
• Xingchu Meng,
• Ze Yu

Affiliations

Zhengfeng Xu

Department of General Surgery, The Fourth Affiliated Hospital, Harbin Medical University, Harbin, Heilong jiang Province, China; The Laboratory of Cytobiology and Molecular Biology, Zhoushan Hospital, Wenzhou Medical University, Zhoushan, Zhejiang Province, China

Hongwei Yu

Department of General Surgery, Zhoushan Hospital, Wenzhou Medical University, Zhoushan, Zhejiang Province, China

Xingchu Meng

Corresponding authors.No.37 Yiyuan Street, Nangang District, Harbin, Heilong jiang Province, 150001, China.; Department of General Surgery, The Fourth Affiliated Hospital, Harbin Medical University, Harbin, Heilong jiang Province, China

Ze Yu

Corresponding authors. No.739 Dingshen Road, Lincheng New District, Zhoushan, Zhejiang Province, 316021, China.; Department of General Surgery, Zhoushan Hospital, Wenzhou Medical University, Zhoushan, Zhejiang Province, China; The Laboratory of Cytobiology and Molecular Biology, Zhoushan Hospital, Wenzhou Medical University, Zhoushan, Zhejiang Province, China